Back to results
US 9,809,562 B2Granted
NAT10 modulators for treating or preventing laminopathies, aging and cancer
AssigneesCambridge Enterprise Limited, Centre National De La Recherche Scientifique
InventorsDelphine Laurence Daniele Larrieu, Raphaël Joël Rodriguez, Sébastien Frédéric Stéphane Britton, Stephen Philip Jackson
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds in the treatment or prevention of disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations, such as laminopathy, premature ageing disorders, normal ageing and cancer (such as a cancer characterized by low levels of LMNA expression).
Claims20
A compound selected from:
- and salts or solvates of any one thereof.
Dependencies are inferred from the claim text.